The new health system is now the second largest in Massachusetts, employing 35,000 and overseeing 1.3 million patients.
Category: Healthcare Finance News
Hospital star ratings released as CMS seeks to update methodology
The number of vulnerable patients, social risk factors, and other issues beyond a provider’s control, lead to misleading ratings, Essential Hospitals says.
In the new age of healthcare consumerism, convenience is king
In an era of shifting attitudes and expectations on the part of patients, providers can no longer be content that the old models will see them through.
Medicare for all: Don’t rip health system apart and start from scratch, insurers and providers say
Government has a history of slashing provider payments for government health programs; Medicare and Medicaid reimburse providers less than the cost of delivering care, AHA says.
Vanguard Healthcare to pay $18 million due to False Claims Act allegations
The DOJ said Vanguard and its skilled nursing facilities delivered "worthless" services to residents between 2010 and 2015.
One more reason to focus on retaining physicians: They generate $2.4 million for their hospitals
Family physicians and internists also represent significant ROI, generating $2.1 million and nearly $2.7 million in net revenue, respectively.
St. Luke’s revenue cycle benefits by offering patients a discounted price for paying upfront
The health system is keeping up with CMS mandates for price transparency, requirements that will only grow over time, senior Finance VP says.
Investing in consumerism and technology requires scale, wise allocation of investments
Health systems should be allocating more resources to technologies that further the mission of creating a consumer-centric industry.
Travel and wait times for healthcare are the worst among professional sectors, Altarum report says.
When travel and wait times were quantified using hourly wage to measure "economic cost of time spent" the costs averaged $89 billion dollars annually, the analysis said.
Senate Finance Committee wants pharma commitment for lower list prices on drugs
End rebates for both Medicare and commercial plans, and they will lower list prices, pharmaceutical executives say.
